2016
DOI: 10.1002/adhm.201600810
|View full text |Cite
|
Sign up to set email alerts
|

Self‐Renewal of Bone Marrow Stem Cells by Nanovesicles Engineered from Embryonic Stem Cells

Abstract: Extracellular vesicles can enhance cell proliferation by stimulating signal transduction and delivering genetic materials, and thus may have applications in regenerative medicine and other therapeutic applications. The processes employed to isolate extracellular vesicles, however, are complex and achieve low yield. To overcome these obstacles, a large-scale, micropore device for generating extracellular vesicle-mimetic nanovesicles that have characteristics similar to those of extracellular vesicles is fabrica… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
19
0

Year Published

2018
2018
2023
2023

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 28 publications
(20 citation statements)
references
References 32 publications
1
19
0
Order By: Relevance
“…4a). As such, we confirmed that EV influenced the self-renewal capacity of MSCs at the genetic level, consistent with Jo et al [18], who used a system of nanovesicles engineered from embryonic stem cells. Merino-González et al [19] reported that the secretion of soluble factors and the release of extracellular vesicles, such as exosomes, could mediate cellular communication, inducing cell differentiation and self-renewal.…”
Section: Discussionsupporting
confidence: 91%
“…4a). As such, we confirmed that EV influenced the self-renewal capacity of MSCs at the genetic level, consistent with Jo et al [18], who used a system of nanovesicles engineered from embryonic stem cells. Merino-González et al [19] reported that the secretion of soluble factors and the release of extracellular vesicles, such as exosomes, could mediate cellular communication, inducing cell differentiation and self-renewal.…”
Section: Discussionsupporting
confidence: 91%
“…The average exosome yield from 10 6 cells is 1 to 4 g/day (16), which cannot easily meet the quantity (100 to 500 g per patient) of exosomes required in a clinical trial (17). Recently, exosome-mimetic nanovesicles (NVs), which have similar size and composition to those of exosomes, have been developed through the serial extrusion of cells through microporous filters (18,19). Similar to exosomes, NVs can also convey the biomolecules of their parental cells to recipient cells.…”
Section: Introductionmentioning
confidence: 99%
“… [22] , who reported that nanovesicles promote the cellular proliferation of mesenchymal stem cells of a murine, enhances signal pathway associated with proliferation, but do not regulate/influence the murine MSCs properties. Finally, these vesicles could provide stable MSCs for other therapeutic applications and regenerative medicine [22] .…”
Section: Exosomes: a Double-edged Swordmentioning
confidence: 99%